Loeb & Loeb-Guided SPAC Ditches Warrants In $145M IPO
A blank-check company focused on biotechnology diverged from the typical path on Thursday by only selling shares in an upsized, $145 million initial public offering steered by Loeb & Loeb LLP....To view the full article, register now.
Already a subscriber? Click here to view full article